Member Info for NicName

I'm not sure an algorithm can be "successful". I'm not sure of your numbers either.

Hardly surprising, it's an algorithm which just responds to a couple of days of up-ticks which itself is just reflecting a general trend which is readily visible from the FTSE charts. But you already knew that, didn't you...

"Same post each day until breakthrough in marketing"

All that demonstrates is a banal intent to stiffle debate. And the 'ditto' posts, vapid.

"...entered the exact same dtails..."
Via a comparison site or direct with providers?

Over 50?

This time it could be different.

There are none so blind as those that will not see.

"And the price model operates at a finer grained level than cabin type - specifically at cabin grade level. For instance Standard Twin cabins may be sub-divided into cabin types F, G, H, I, J, K and L."

That part sounds like a scam.

But unfortunately that's a 3yr outlook based on a 20% increase in the estate with minimal debt. Maybe minimal debt would involve another placing.

Bucolic, if you read you will see that my comment was to Dr. Nielson who was implying that a compound acting as a placebo could or should have no side effects. Liam pointed out that the trials identified some reported side effects. MED3000 includes alcohol, in similar volume to that found in many hand sanitisers where its toxicity is employed to'kill' bacteria, viruses. Fortunately I think most here will understand what you are really trying put across - that it is always toxic but poisonous by degree. Inhalation of 'spirits' will often give rise to headaches in humans.

Is alcohol not a poison Dr. Nelson?

"it is true that some consumers do buy scientifically questionable products eg Flexiseq."

Within which lies the placebo effect cohort.

"As I keep saying. I do think MED3000 will work for some people and some people will buy it."

I think that might be better phrased as "may work" and "some people will try it".
Of those for whom it is in any way efficacious initially will it be so in the longer term and will they continue to buy it?

There is some difference between suffering from "stiff joints" and suffering from 'floppy willy' although it's quite possible that many individuals will suffer from both, particularly in later life. I think those that do would view the two complaints somewhat differently although 'mechanical stimulation' may provide some relief in both cases.

As with any 'lube' I can see some may get some fun out of it, but the point here is it is claiming to be a solution for ED. It is that group who are the target market. It is supposed to help them with what is, to them, a distressing condition.

"The shelves of your average pharmacy are stacked with products that contain no active ingredients. Consider all the skin creams, eye ointments, and so on, that sell in their millions."

I think you will find most do assert to include some active substance. Or are you just thinking of cosmetics?

"So the clear answer to NicName's fatuous question is yes of course, people queue up to buy things with no active ingredients to cure their ailments, each and every day."

You may want to think that one through again. If you are expecting MED3000 to sold "OTC" without prescription and thus readily available on the shelves of pharmacies the consideration of whether people will buy it as a remedy for ED can hardly be fatuous.

"If it works without an "active ingredient" because the product itself works with a yet to be fully understood way then why not"

But you don't know it works, you are simply looking for something to relieve an ailment. Would you buy 'pain relief' tablets made purely of excipients?

"Fizzy water is not needed to quench thirst, but it sells."

Quite, people don't buy fizzy water to resolve an ailment.

Guidance.
Fincap are broker & nomad, Research Tree sponsored promotors. Sell-side spiel.

If you were to visit the pharmacy to seek something to relieve an ailment and saw on the shelf a product with no active ingredient, would you buy it?

Lacking in substance but good spin for a P&D I guess

Nervous might be an appropriate adjective, given past performance.

Wonder if Credit Suisse has a line of stock to sell...